The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study. Patients diagnosed with the disease, which is tied to exposure to asbestos, have a median survival rate of about one year.
from Top Health News – ScienceDaily http://bit.ly/1DDC1dk via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1bkQq55
No comments:
Post a Comment